Skip to content

Logs: Bennett Institute

The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
Status Project Workspace Request ID Backend Jobs User Started View request
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16669 TPP 2/2 Bang Zheng 3 years, 1 month ago 23 March 2023 22:39:57 UTC View, Job request 16669
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16667 TPP 1/1 Bang Zheng 3 years, 1 month ago 23 March 2023 17:00:30 UTC View, Job request 16667
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16660 TPP 1/1 Bang Zheng 3 years, 1 month ago 23 March 2023 16:32:05 UTC View, Job request 16660
Failed COVID-19 Vaccine Effectiveness vax-fourth-dose-rd-baseline 16659 TPP 4/6 Andrea Schaffer 3 years, 1 month ago 23 March 2023 15:48:45 UTC View, Job request 16659
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16658 TPP 4/4 Linda Nab 3 years, 1 month ago 23 March 2023 14:23:20 UTC View, Job request 16658
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16657 TPP 0/1 Bang Zheng 3 years, 1 month ago 23 March 2023 13:43:15 UTC View, Job request 16657
Succeeded COVID-19 Vaccine Effectiveness vax-fourth-dose-rd-baseline 16642 TPP 1/1 Andrea Schaffer 3 years, 1 month ago 23 March 2023 10:16:16 UTC View, Job request 16642
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16640 TPP 0/1 Bang Zheng 3 years, 1 month ago 23 March 2023 11:24:48 UTC View, Job request 16640
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16637 TPP 0/1 Bang Zheng 3 years, 1 month ago 23 March 2023 09:47:44 UTC View, Job request 16637
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16630 TPP 0/1 Bang Zheng 3 years, 1 month ago 23 March 2023 07:14:37 UTC View, Job request 16630
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16629 TPP 0/1 Bang Zheng - View, Job request 16629
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16628 TPP 0/1 Bang Zheng 3 years, 1 month ago 22 March 2023 23:27:59 UTC View, Job request 16628
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16627 TPP 0/1 Bang Zheng 3 years, 1 month ago 22 March 2023 22:35:06 UTC View, Job request 16627
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16624 TPP 0/1 Bang Zheng 3 years, 1 month ago 22 March 2023 20:56:58 UTC View, Job request 16624
Succeeded COVID-19 Vaccine Effectiveness vax-fourth-dose-rd-baseline 16605 TPP 4/4 Andrea Schaffer 3 years, 1 month ago 22 March 2023 15:31:04 UTC View, Job request 16605
Failed Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16602 TPP 0/3 Linda Nab 3 years, 1 month ago 22 March 2023 15:07:29 UTC View, Job request 16602
Failed Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16600 TPP 0/4 Linda Nab 3 years, 1 month ago 22 March 2023 14:59:45 UTC View, Job request 16600
Succeeded Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16586 TPP 1/1 Bang Zheng 3 years, 1 month ago 21 March 2023 22:45:36 UTC View, Job request 16586
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16585 TPP 0/1 Bang Zheng 3 years, 1 month ago 21 March 2023 21:35:52 UTC View, Job request 16585
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16576 TPP 5/5 Linda Nab 3 years, 1 month ago 21 March 2023 13:13:11 UTC View, Job request 16576
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16575 TPP 1/1 Linda Nab 3 years, 1 month ago 21 March 2023 12:53:24 UTC View, Job request 16575
Succeeded Effectiveness of sotrovimab/molnupiravir use vs non-use mabsavs-usernonuser-ccw 16574 TPP 1/1 Linda Nab 3 years, 1 month ago 21 March 2023 11:50:25 UTC View, Job request 16574
Failed Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 16573 TPP 0/1 Bang Zheng 3 years, 1 month ago 21 March 2023 20:29:48 UTC View, Job request 16573
Succeeded OpenSAFELY Internal opensafely-internal-interactive 16533 TPP 9/9 Lucy Bridges 3 years, 1 month ago 20 March 2023 13:41:28 UTC View, Job request 16533
Succeeded GP appointments during COVID winter-pressures 16526 TPP 2/2 Lisa Hopcroft 3 years, 1 month ago 20 March 2023 10:16:34 UTC View, Job request 16526